Knee Procedures without Infection DRG 489 Medicare Payment

Early perioperative analgesia and blood management trials: Studies evaluate multimodal analgesic protocols, regional nerve blocks, and tranexamic acid use in patients undergoing non-infection knee procedures (e.g., total or partial knee arthroplasty, arthroscopic repairs) to reduce intraoperative blood loss, opioid consumption, and immediate postoperative complications. The population typically includes adults admitted for elective or urgent knee surgery without infectious diagnoses, often stratified by age, comorbidity burden, and baseline hemoglobin. Results inform inpatient length of stay, transfusion requirements, and resource utilization, directly impacting provider care pathways and payer reimbursement through effects on LOS and complication-related costs.
Comparative effectiveness trials of surgical techniques and implants: Randomized or pragmatic comparative studies examine different surgical approaches (e.g., minimally invasive vs standard arthroplasty, cemented vs cementless fixation, or various implant designs) and perioperative protocols in patients receiving knee procedures for degenerative or traumatic indications without infection. These trials focus on functional outcomes, readmission rates, and short-term complication profiles in the acute inpatient period and early rehabilitation phase. Findings help clinicians choose techniques that optimize early recovery and reduce costly readmissions or revisions, which are key drivers of inpatient and post-acute reimbursement for this DRG.
Post-discharge recovery, rehabilitation, and health-economic outcomes research: Observational cohorts and interventional trials test inpatient-to-outpatient transitional care models, early mobilization protocols, and structured physical therapy regimens for patients discharged after non-infectious knee procedures, including analyses of 30- and 90-day readmissions, functional status, and total episode-of-care costs. These studies often enroll medically complex or older adults who are at higher risk for delayed recovery or discharge to skilled nursing facilities. The evidence helps payers and hospitals design discharge planning and bundled-payment strategies to lower post-acute utilization and improve cost-effectiveness for episodes classified under DRG 489.

Early perioperative analgesia and blood management trials: Studies evaluate multimodal analgesic protocols, regional nerve blocks, and tranexamic acid use in patients undergoing non-infection knee procedures (e.g., total or partial knee arthroplasty, arthroscopic repairs) to reduce intraoperative blood loss, opioid consumption, and immediate postoperative complications. The population typically includes adults admitted for elective or urgent knee surgery without infectious diagnoses, often stratified by age, comorbidity burden, and baseline hemoglobin. Results inform inpatient length of stay, transfusion requirements, and resource utilization, directly impacting provider care pathways and payer reimbursement through effects on LOS and complication-related costs.
Comparative effectiveness trials of surgical techniques and implants: Randomized or pragmatic comparative studies examine different surgical approaches (e.g., minimally invasive vs standard arthroplasty, cemented vs cementless fixation, or various implant designs) and perioperative protocols in patients receiving knee procedures for degenerative or traumatic indications without infection. These trials focus on functional outcomes, readmission rates, and short-term complication profiles in the acute inpatient period and early rehabilitation phase. Findings help clinicians choose techniques that optimize early recovery and reduce costly readmissions or revisions, which are key drivers of inpatient and post-acute reimbursement for this DRG.
Post-discharge recovery, rehabilitation, and health-economic outcomes research: Observational cohorts and interventional trials test inpatient-to-outpatient transitional care models, early mobilization protocols, and structured physical therapy regimens for patients discharged after non-infectious knee procedures, including analyses of 30- and 90-day readmissions, functional status, and total episode-of-care costs. These studies often enroll medically complex or older adults who are at higher risk for delayed recovery or discharge to skilled nursing facilities. The evidence helps payers and hospitals design discharge planning and bundled-payment strategies to lower post-acute utilization and improve cost-effectiveness for episodes classified under DRG 489.

OpenPayer

Summary & Overview

Knee Procedures without Principal Diagnosis of Infection without CC/MCC: Inpatient Reimbursement Overview

DRG 489 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes